Prof. Dr. A.T. van Oosterom (EORTC President 2000-2003)
10 Nov 2021
The international oncology community has lost a true leader. Professor Allan T. van Oosterom studied in The Netherlands and graduated from the University of Leiden. He obtained his PhD in 1976, trained at the US National Cancer Institute and subsequently in 1978 became a Lecturer at the Royal Marsden Hospital in the United Kingdom. He returned to The Netherlands as a Senior Lecturer at the University of Leiden, and then moved to Antwerp in Belgium where he was Head of Oncology for 10 years and subsequently transferred to Leuven. Professor A.T, van Oosterom was always involved in clinical research and more specifically in the field of sarcomas, gynaecological and uro-genital tumours. In that respect, he had long association with the EORTC. He first became a member of the EORTC back in 1974 and took position on the Board of Directors in 1984, and was the EORTC President 2000-2003. In addition, he was a member of many organisations and was notably President of the Federation of European Cancer Societies (FECS). Professor A.T. van Oosterom inspired many doctors and scientists in carrying out forefront cancer clinical research, contributing through his own research agenda and through that of others to major therapeutic improvement for cancer patients.
It is with great sadness that we learn that Professor A.T. van Oosterom passed away. EORTC has lost a major peer who contributed to making oncology what it is today. His vision and dedication, relentlessly chasing the next oncological challenge to solve, collaborating across the world, inspired many oncologists worldwide.
We will remember Professor A.T. van Oosterom as a passionate and talented oncology leader.
Related News
EORTC participation at ISPOR Europe 2025 conference
7 Nov 2025
EORTC Quality of Life Group participating at the ISOQOL 2025 Conference
22 Oct 2025
New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
21 Oct 2025
EORTC celebrates the 100th anniversary of p-value on World Statistics Day
20 Oct 2025
EORTC Announces Final Overall Survival Results from the PEACE-3 Trial
19 Oct 2025
Results from EORTC trial define new standard of care for aggressive brain tumours
18 Oct 2025
EORTC’s presence at ESMO 2025
17 Oct 2025
EORTC’s presence at EANO 2025
16 Oct 2025
EORTC celebrates Pink October: shaping the future of breast cancer care
15 Oct 2025
EORTC shines a light on advancements in radioligand therapy
8 Oct 2025
